HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

mofarotene

structure given in first source
Also Known As:
4-((2-(p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)propenyl)phenoxy)ethyl))morpholine; Ro 40-8757; Ro-40-8757; arotinoid Ro 40-8757
Networked: 15 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fink-Puches, Regina: 1 article (12/2004)
2. Helige, Christine: 1 article (12/2004)
3. Hofmann-Wellenhof, Rainer: 1 article (12/2004)
4. Smolle, Josef: 1 article (12/2004)
5. Boiocchi, Mauro: 1 article (02/2003)
6. De Rossi, Anita: 1 article (02/2003)
7. Dolcetti, Riccardo: 1 article (02/2003)
8. Righetti, Elisabetta: 1 article (02/2003)
9. Cariati, Roberta: 1 article (02/2003)
10. Zancai, Paola: 1 article (02/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Lymphoma (Lymphomas)
3. Melanoma (Melanoma, Malignant)
4. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Enzymes
2. Fluorouracil (Carac)
3. Cell Cycle Proteins
4. Vinculin
5. Etoposide (VP 16)
6. Cisplatin (Platino)
7. Retinoids
8. mofarotene
9. Complementary DNA (cDNA)
10. Fenretinide

Related Therapies and Procedures

1. Chemoprevention